ライフサイエンスコーパス: vena

1 ein to the level of cortisol in the inferior vena cava >= 5.

2 +/- 0.10) and descending aorta and superior vena cava (0.14 L/min +/- 0.12).

3 iosus (16/47, 34%), persistent left superior vena cava (14/47, 30%), and abnormal branching of the ri

4 re (17 +/- 2%), thorax (14 +/- 2%), inferior vena cava (23 +/- 2%) and liver (23 +/- 2%) (all P </= 0

5 ated abnormality followed by double superior vena cava (9.78%).

6 embolism (five of 23; 22%), and the inferior vena cava (four of 23; 17%).

7 l treatment of chronic occlusion of inferior vena cava (IVC) and iliocaval confluence with angioplast

8 with incidental finding of complete inferior vena cava (IVC) and obliteration.

9 ng the IPVE, and using the aorta or inferior vena cava (IVC) as the input function.

10 e inside diameters of the aorta and inferior vena cava (IVC) at the top of L2 and the bottom of L4 an

11 Failure to remove a retrievable inferior vena cava (IVC) filter can cause severe complications wi

12 after implantation of an absorbable inferior vena cava (IVC) filter in a swine model.

13 erlapping heparin and warfarin, and inferior vena cava (IVC) filter placement were not independent pr

14 e relationship between prophylactic inferior vena cava (IVC) filter use, mortality, and VTE.

15 Inferior vena cava (IVC) filters are widely used for prevention o

16 The use of inferior vena cava (IVC) filters for prevention of venous thrombo

17 The use of inferior vena cava (IVC) filters in this population has been incr

18 divided on the role of prophylactic inferior vena cava (IVC) filters to prevent PE.

19 ecent studies concerning the use of inferior vena cava (IVC) filters.

20 unseeded control) were implanted as inferior vena cava (IVC) interposition grafts in juvenile lambs.

21 Obstruction of the inferior vena cava (IVC) is infrequent, membranous obstruction of

22 ith prothrombotic propensity in the inferior vena cava (IVC) ligation model.

23 neutrophil-rich clots after partial inferior vena cava (IVC) ligation than those that formed in wild-

24 (WT) littermates underwent partial inferior vena cava (IVC) ligation to induce venous thrombosis.

25 omponents of the venous flow in the inferior vena cava (IVC) of 14 Fontan patients and 11 normal cont

26 hat 48-hour flow restriction in the inferior vena cava (IVC) results in the development of thrombi st

27 Here, using a murine DVT model of inferior vena cava (IVC) stenosis, we demonstrate that mice with

28 er is associated with renal vein or inferior vena cava (IVC) thrombus in up to 10% of cases.

29 t has been suggested for the use of inferior vena cava (IVC) value instead of FHVP to calculate HVPG

30 ption of the hepatic segment of the inferior vena cava (IVC) were the vascular anomalies.

31 ging tumors with extension into the inferior vena cava (IVC).

32 ) and infrahepatic and suprahepatic inferior vena cava (IVC).

33 tion of the mesentericoportal vein (n = 24), vena cava (n = 3), or hepatic vein (n = 3).

34 ; P=0.005), whereas persistent left superior vena cava (P=0.85), ventricular septal defect (P=0.12),

35 ocardium in late frames as compared with the vena cava (percentage injected dose per gram, ctl: 21.4+

36 artial ligation of the suprahepatic inferior vena cava (pIVCL) to simulate congestive hepatopathy-ind

37 thy through partial ligation of the inferior vena cava (pIVCL).

38 t on a rare case of persistent left superior vena cava (PLSVC) with absent right superior vena cava (

39 vena cava (PLSVC) with absent right superior vena cava (RSVC).

40 ency of the common wall between the superior vena cava (SVC) and the right upper pulmonary vein (RUPV

41 (PV) origin, those arising from the superior vena cava (SVC) can precipitate atrial fibrillation (AF)

42 Biatrial drainage of the right superior vena cava (SVC) is a rare form of interatrial shunting t

43 PURPOSE OF REVIEW: Superior vena cava (SVC) is one of the most important nonpulmonar

44 ility of durable pulmonary vein and superior vena cava (SVC) isolation between radiofrequency ablatio

45 Superior vena cava (SVC) tears are one of the most lethal complic

46 ntral veins of the thorax including superior vena cava (SVC), brachiocephalic (BCV), subclavian (SCV)

47 lt from vascular obstruction of the superior vena cava (SVC).

48 n into aorto-iliac/visceral arteries and the vena cava (temporal resolution, five images per second;

49 RP was achieved by cannulating the aorta and vena cava after death.

50 comas that most commonly affect the inferior vena cava and account for 5% of all leiomyosarcomas.

51 For the superior vena cava and brachiocephalic veins, the reconstructions

52 T for PLD facilitates total hepatectomy with vena cava and caval flow preservation.

53 e into the left subclavian vein and superior vena cava and evaluated for up to 90 minutes.

54 native liver with narrow access to inferior vena cava and fragile venous wall may lead to venous tea

55 of the adrenal vein drainage to the inferior vena cava and hepatic vein or of the inferior phrenic ve

56 pressor treatment by evaluating the inferior vena cava and other cardiac structures.Lung ultrasound c

57 ed-chest, large-vessel anastomosis (superior vena cava and pulmonary artery [PA] or bidirectional Gle

58 vant (>3 mm) apposition between the inferior vena cava and pulmonary venous atrium (cavoatrial overla

59 ugh a region of overlap between the inferior vena cava and pulmonary venous atrium is feasible.

60 avascular balloon positioned at the superior vena cava and right atrial junction (SVC-RAJ) reduces so

61 tracer bolus dispersion in blood between the vena cava and the arterial tree was applied.

62 collected from the hepatic vein and superior vena cava and underwent protein profiling for a panel of

63 Tumors invading the vena cava and/or the hepatocaval confluence are indicati

64 ualized unequivocally in the murine inferior vena cava as hot spots in vivo by simultaneous acquisiti

65 icle cavity, left atrial cavity, or inferior vena cava as the IDIF.

66 ation was performed from within the inferior vena cava at areas of esophageal contact.

67 re was a 17% difference in the image-derived vena cava blood activity at 60 min, compared with the ex

68 3%-100%), whereas 55% +/- 19 of the inferior vena cava blood flowed to the left PA (range, 22%-82%).

69 ntan circulation, 87% +/- 13 of the superior vena cava blood flowed to the right PA (range, 63%-100%)

70 osity measures, pulse generator and superior vena cava coil location, and angle of lead exit from the

71 nfidence interval 0.65-0.89) or the inferior vena cava collapsibility index (area under the curve 0.6

72 us pressure (R = 0.58), whereas the inferior vena cava collapsibility index and the internal jugular

73 cators, with a significantly higher inferior vena cava collapsibility index on day 0 than nonacidotic

74 of central venous pressure than the inferior vena cava collapsibility index or the internal jugular v

75 Inferior vena cava collapsibility index was not an independent pr

76 , low stroke volume index, and high inferior vena cava collapsibility index, which improved with subs

77 or contractility and assessment of inferior vena cava collapsibility.

78 present a unique case, in which the inferior vena cava compression by a total artificial heart was in

79 re available in 65 patients, as the inferior vena cava could not be visualized in two patients.

80 Transmural pressure of the superior vena cava decreased during inspiration, whereas the tran

81 t between the right portal vein and inferior vena cava detected on postnatal ultrasound examination.

82 An inferior vena cava diameter < 2 cm predicted a central venous pre

83 pressure (< 10 mm Hg) was 0.91 for inferior vena cava diameter (95% confidence interval 0.84-0.98),

84 ransesophageal echocardiography, of inferior vena cava diameter (IVC) measured using transthoracic ec

85 0.0001), respiratory variability of inferior vena cava diameter (r = 0.42; p < 0.01), and pulse press

86 ve study, respiratory variations of superior vena cava diameter (SVC) measured using transesophageal

87 The maximal inferior vena cava diameter correlated moderately with central ve

88 venous pressure after adjusting for inferior vena cava diameter in a multiple linear regression model

89 ut vasopressor support, the maximal inferior vena cava diameter is a more robust estimate of central

90 Respiratory variation in vena cava diameter measured by ultrasound (distensibilit

91 The proximal mouse vena cava diameter was 2.54 +/- 0.30 mm.

92 to width ratio (aspect ratio), the inferior vena cava diameter, and the percent collapse of the infe

93 ntegral, respiratory variability of inferior vena cava diameter, or pulse pressure variation.

94 ment of the central isthmus (RCA to inferior vena cava distance).

95 Patients with less vena cava distensibility were not as likely to be fluid

96 The collapsibility index of the inferior vena cava during a deep standardized inspiration is a si

97 ted into the grafts through the suprahepatic vena cava during cold storage (VSOP-NO group; n=20).

98 ential expression pattern in mouse aorta vs. vena cava ECs, which cannot be explained by the differen

99 s when they become firmly embedded along the vena cava endothelium.

100 in thrombosis (A 0%, B 24%, C 76%), inferior vena cava filter (A 0%, B 31%, C 69%), and renal artery

101 Vena cava filter (VCF) placement for pulmonary embolism

102 Early prophylactic placement of a vena cava filter after major trauma did not result in a

103 Early placement of a vena cava filter did not result in a significantly lower

104 than no placement of a filter (13.9% in the vena cava filter group and 14.4% in the control group; h

105 y embolism developed in none of those in the vena cava filter group and in 5 (14.7%) in the control g

106 Among the 46 patients in the vena cava filter group and the 34 patients in the contro

107 verity were assigned to retrievable inferior vena cava filter implantation plus anticoagulation (filt

108 Insertion of a retrievable inferior vena cava filter in patients randomized to the filter gr

109 d with a significant bleeding risk, inferior vena cava filter insertion compared with anticoagulant t

110 we assessed the association between inferior vena cava filter insertion for known significant bleedin

111 surgical pulmonary embolectomy, and inferior vena cava filter insertion.

112 indication to anticoagulant agents to have a vena cava filter placed within the first 72 hours after

113 Trauma patients and inferior vena cava filter placements were excluded.

114 embolism, the use of a retrievable inferior vena cava filter plus anticoagulation compared with anti

115 Whether early placement of an inferior vena cava filter reduces the risk of pulmonary embolism

116 r thrombosis risk factors, avoiding inferior vena cava filter usage except in specified circumstances

117 The effectiveness of inferior vena cava filter use among patients with acute symptomat

118 heparin (29%), dalteparin (40%), or inferior vena cava filters (20%) were not statistically different

119 Evidence that vena cava filters (VCFs) are beneficial is limited.

120 change in the society guidelines, the use of vena cava filters (VCFs) continues to rise.

121 Although retrievable inferior vena cava filters are frequently used in addition to ant

122 erventions such as thrombolysis and inferior vena cava filters are reserved for limited circumstances

123 aim to define prolonged retrievable inferior vena cava filters dwell time by determining the inflecti

124 investigate the survival effects of inferior vena cava filters in patients with venous thromboembolis

125 Patients with retrievable inferior vena cava filters in place beyond 7 months may benefit f

126 Although chronically implanted inferior vena cava filters may result in filter-related morbidity

127 inform the management of fractured inferior vena cava filters on the basis of results from a tertiar

128 l is effective in removing embedded inferior vena cava filters refractory to standard retrieval and h

129 Superior vena cava filters should be avoided.

130 Until further data emerge, thrombolysis and vena cava filters should be reserved for patients in who

131 Inferior vena cava filters were placed in 46%.

132 y impacted retrieval of retrievable inferior vena cava filters with prolonged dwell times; however, t

133 g, feeding tube placement, tracheostomy, and vena cava filters) among nursing home residents to rates

134 is is best reserved for severe VTE; inferior vena cava filters, ideally the retrievable variety, shou

135 growth in placement of retrievable inferior vena cava filters, retrieval rates remain low.

136 be diminished by leg compression devices or vena cava filters.

137 e flow were performed by increasing inferior vena cava flow.

138 trial fibrillation triggered from a superior vena cava focus (1 patient) adjacent to the right PN or

139 t anastomosis of liver allograft to a Dacron vena cava graft can be a feasible solution if traditiona

140 Vena cava IDIF (n = 7) was compared with the left ventri

141 after acute insulin treatment, using a mouse vena cava IDIF approach.

142 The mouse vena cava IDIF provides repeatable assessment of the blo

143 ardial glucose uptake rates (rMGU) using the vena cava IDIF were calculated at baseline (n = 8), afte

144 alysis was systematically assessed using the vena cava image-derived blood input function (IDIF).

145 en, kidney, brain, lung, vitreous humor, and vena cava in comparison to untreated controls (P </= .05

146 increased net and peak flow in the inferior vena cava in end inspiration compared with end expiratio

147 anipulation and improve exposure of inferior vena cava in patients with massive hepatomegaly related

148 orifice of superior mesenteric artery (SMA), vena cava inferior confluence (CVC), abdominal aorta bif

149 thrombosis induced by flow reduction in the vena cava inferior, we identified blood-derived high-mob

150 odegradable TEVGs were implanted as inferior vena cava interposition conduits in 2 groups of C57BL/6

151 s that were surgically implanted as inferior vena cava interposition grafts in SCID/bg mice.

152 nctive therapeutic modalities (thrombolysis, vena cava interruption, venous stenting).

153 Persistent left superior vena cava is a rare but important congenital vascular an

154 Additionally, the transmural pressure of the vena cava is decreased, whereas the transmural pressure

155 us oxygen saturation (ScvO2) in the superior vena cava is predominantly determined by cardiac output,

156 Baseline renal vein and inferior vena cava levels of inflammatory markers were measured a

157 tibility to venous thrombosis after inferior vena cava ligation at 12 or 18 months of age (P<0.05 ver

158 ysis on thrombosis were examined by inferior vena cava ligation in congenic mice with and without alp

159 Venous thrombosis was induced by inferior vena cava ligation in mice with genetic deletion of TGFb

160 decrease the theoretical risk of a positive vena cava margin or hematologic metastases.

161 temporary preload reduction during inferior vena cava occlusion initially induced an expansion of LV

162 erior vena cava thrombosis, chronic inferior vena cava occlusion, and pain from retroperitoneal or bo

163 ume loop data obtained during acute inferior vena cava occlusion.

164 Venous thrombosis was induced in the vena cava of BALB/C mice, and temporal changes in T1 rel

165 vein thrombosis was induced in the inferior vena cava of male BALB/C mice.

166 nt platelet microparticles into the inferior vena cava of mice and harvested endothelial cells from t

167 delivered in 4 and 1 swine from the inferior vena cava onto a forcefully deviated esophagus.

168 Despite significant inferior vena cava or hepatic venous compression in 65%, hepatic

169 n, 18 kg) kg of whom 4 had occluded inferior vena cava or iliac veins and 2 had previous complex vasc

170 tion of a roughened catheter into either the vena cava or the aorta.

171 llate ganglia; (3) occlusion of the inferior vena cava or thoracic aorta; (4) transient ventricular i

172 Vena cava pertinent diameters were measured 15-20 mm cau

173 ne subject, a congenital left-sided superior vena cava precluded right-sided capture.

174 une 2009 and September 2018 using either the vena cava preserving piggyback technique or caval replac

175 , patients had significantly higher inferior vena cava pressures (15.6 versus 13.7 mm Hg; P=0.007), b

176 hout partial-volume correction, the inferior vena cava provides a reliable and reproducible IDIF for

177 The association between vena cava reconstruction technique and stage of postoper

178 remains controversial whether the choice of vena cava reconstruction technique impacts AKI.

179 her the collapsibility index of the inferior vena cava recorded during a deep standardized inspiratio

180 computer modeling was used to determine the vena cava recovery coefficient.

181 e usefulness of respiratory variation in the vena cava requires confirmatory studies.

182 Aortic or superior vena cava rim deficiencies were more common in cases tha

183 The presented IDIF from the vena cava showed a robust determination of CMRGlc using

184 ach]; the lowest proportion was for inferior vena cava size [75%]).

185 unted for (aortic valve was 91% and inferior vena cava size was 58%).

186 (aortic valve was 96% [highest] and inferior vena cava size was 78% [lowest]) and decreased when nonv

187 A young woman with a benign superior vena cava stenosis due to a tunneled internal jugular ve

188 umor-bearing and control mice in an inferior vena cava stenosis model.

189 mice produced a thrombus 48 h after inferior vena cava stenosis whereas 90% of wild-type mice did.

190 n a restricted-flow model of murine inferior vena cava stenosis.

191 Specifically, superior vena cava syndrome may warrant radiation, chemotherapy,

192 Superior vena cava syndrome was more common in the non-cardiac su

193 ogy department with symptoms of the superior vena cava syndrome.

194 atlak slope was significantly higher for the vena cava than atrial IDIF (mL/g/min, ctl: 0.11+/-0.02 v

195 a principal discharge diagnosis of inferior vena cava thrombosis (International Classification of Di

196 Vena cava thrombosis can represent a surgical challenge

197 T in the treatment of patients with inferior vena cava thrombosis in the United States.

198 ombolysis (CDT) in the treatment of inferior vena cava thrombosis is unknown.

199 Among 2674 patients admitted with inferior vena cava thrombosis, 718 (26.9%) underwent CDT.

200 tions included filter-related acute inferior vena cava thrombosis, chronic inferior vena cava occlusi

201 r cardiopulmonary bypass because of extended vena cava thrombosis; in 2 patients, a simultaneous ster

202 The vena cava time-activity curve is therefore a minimally i

203 lation of a balloon catheter in the inferior vena cava to identify the lower limit of cerebral autore

204 Puncture through the inferior vena cava to the pulmonary venous atrium may be an effec

205 recipient's HV confluence, and in 3 cases, a vena cava triangulation was necessary; 6 MSUD grafts req

206 dex and collapsibility index of the inferior vena cava under a deep standardized inspiration using tr

207 ng recipient hepatectomy rendered the native vena cava unsalvageable.

208 esophagus was deflected toward the inferior vena cava using an esophageal deviation balloon, and abl

209 fraction, mitral regurgitation, and inferior vena cava variability) and correlated abnormalities in s

210 and recruitment of platelets to the inferior vena cava wall after DVT induction were reduced in MC-de

211 or bladder with abdominal aorta and inferior vena cava was isolated and orthotopically sutured to the

212 PVs plus empirical isolation of the superior vena cava was performed in all.

213 In addition, the donor vena cava was too short to bridge the caval defect for i

214 alignment defects, and interrupted inferior vena cava with azygos continuation.

215 ided gallbladder and an interrupted inferior vena cava with azygous continuation.

216 er, and the percent collapse of the inferior vena cava with inspiration (collapsibility index) by ult

217 f chronic indwelling CVC in the low superior vena cava with thrombus in situ was established after fe

218 with a flattened right lobar portal vein and vena cava without any visible active bleeding.

219 ing (index of collapsibility of the superior vena cava>/=36%), inotropic support (left ventricular fr

220 nonsurgical crossing from a donor (superior vena cava) to a recipient (PA) vessel and endovascular s

221 vant index of collapsibility of the superior vena cava), or increased vasopressor support (right vent

222 chian ridge, crista terminalis, and superior vena cava); or arm 3, standard approach + ablation of le

223 ); ascending aorta, 191 (121, 261); superior vena cava, 137 (77, 197); ductus arteriosus, 187 (109, 2

224 68); ascending aorta, 41 (29, 53); superior vena cava, 29 (15, 43); ductus arteriosus, 41 (25, 57);

225 right phrenic nerve pacing from the superior vena cava, all patients underwent diaphragmatic electrom

226 platelet deposition in the ligated inferior vena cava, and diminished platelet activation in vitro.

227 right coronary artery (RCA) to the inferior vena cava, and from the RCA to the tricuspid valve annul

228 y of the abdomen, heart, chest, and inferior vena cava, and many variations in technique, protocols,

229 es, septal defects, persistent left superior vena cava, and patent ductus arteriosus, were present in

230 induced by flow restriction in the inferior vena cava, APP-KO mice, as well as chimeric mice with se

231 KG-Ibeta isoform expressed equally in TD and vena cava, both being approximately 2 times higher than

232 passage of peak activity was observed in the vena cava, but the area under the curve over 2 min was s

233 rombosis created by ligation of the inferior vena cava, HO-1 expression is markedly induced.

234 Following ligation of the inferior vena cava, HO-1(-/-) mice exhibited increased nuclear fa

235 scle tissues, such as the aorta and inferior vena cava, in which Mypt1 E23 is predominately skipped.

236 triotomy to the inferior vena cava, superior vena cava, or tricuspid annulus or by ablating focally i

237 After catheterization of the inferior vena cava, right atrium, foramen ovale, and left atrium

238 n from the lateral atriotomy to the inferior vena cava, superior vena cava, or tricuspid annulus or b

239 rom the right or left lung into the inferior vena cava, through drainage into the hepatic vein, right

240 All pulmonary veins, including the superior vena cava, were successfully isolated.

241 We hypothesize that inferior vena cava-inferior atrial ganglionated plexus nerve acti

242 Because vascular injury in the superior vena cava-right atrium during transvenous lead extractio

243 useful in characterizing ILA in the superior vena cava-right atrium region.

244 Mouse inferior vena cava-to-carotid interposition isografts were comple

245 of the site of obstruction and the inferior vena cava.

246 femoral vein through the adjoining inferior vena cava.

247 the opposite trend was shown in the superior vena cava.

248 (n = 4) and C57BL/6 mice (n = 5), using the vena cava.

249 catheter because of stenosis in the superior vena cava.

250 ha protein in TD compared with the aorta and vena cava.

251 bcostal four chamber, and subcostal inferior vena cava.

252 ruction of the iliofemoral veins or inferior vena cava.

253 part of the right lung entering the superior vena cava.

254 eric arterioles, or ligation of the inferior vena cava.

255 , the left atrial appendage and the superior vena cava.

256 s in the right ventricular apex and superior vena cava.

257 luster between the right atrium and superior vena cava.

258 luding filter migration or thrombosis of the vena cava.

259 Robin sequence, and persistent left superior vena cava.

260 g aorta, main pulmonary artery, and superior vena cava.

261 partial ligation (stenosis) of the inferior vena cava.

262 increased thrombus frequency in the inferior vena cava.

263 pport for cannulation of the swine aorta and vena cava.

264 in retrograde flow, greatest in the superior vena cava.(C) RSNA, 2019Online supplemental material is

265 ; all P < .01), particularly in the superior vena cava.ConclusionFour-dimensional flow MRI had good-t

266 y artery=26, pulmonary vein=21, and superior vena cava=12).

267 and LVIDs indices, more collapsible inferior vena cavae (IVC), and higher heart rates than survivors.

268 ed at different levels: the junction between vena cavae and right atrium; the tricuspid annulus; or b

269 xons follow veins, specifically the superior vena cavae and sinus venosus, to reach these targets.

270 ressing the receptor Ednra to project to the vena cavae leading to the heart.

271 1680 also reduces thrombosis in the inferior vena cavae of both control mice and mice administered aP

272 6 Mongrel hound dogs, superior and inferior vena cavae were isolated and individual lesions were cre

273 rincipally a line of block (LoB) between the vena cavae, are formed; if this LoB does not form, class

274 principal diagnosis of proximal or inferior vena caval deep vein thrombosis and treated with CDT fro

275 Inferior vena caval filters (IVCFs) may prevent recurrent pulmona

276 d portal vein thrombosis, and 1 had inferior vena caval thrombosis.

277 ntraindications to anticoagulation, inferior-vena-caval filters can be considered, but their use need

278 by anastomosis of genicular artery with one vena comitans while leaving one efferent vein for draina

279 th noncentral dMR had a wider pre-procedural vena contracta (8.5 +/- 2.0 mm vs. 6.9 +/- 2.2 mm, p = 0

280 considering only 3 quantitative measures of vena contracta and PISA-based effective regurgitant orif

281 convergence region (PFCR) and measuring the vena contracta area are highly feasible.

282 hods to directly measure the regurgitant jet vena contracta area are presented, along with recent cli

283 Patients in whom vena contracta area could be reduced >50% had a smaller

284 more reduced in patients in whom regurgitant vena contracta area was reduced by >50% compared with th

285 ately after NIMR creation and at euthanasia; vena contracta area, mitral annular dimension, left vent

286 derate mitral regurgitation and an increased vena contracta area.

287 pler 3D TEE was determined as the product of vena contracta areas defined by direct planimetry and ve

288 +/-0.3cm(2) versus 0.4+/-0.2cm(2); P<0.001), vena contracta width (1.1+/-0.5 cm versus 0.6+/-0.3 cm;

289 0 ms increase QLV; P=0.02) and a decrease in vena contracta width (P<0.001).

290 MR reduction at 6 months (absolute change in vena contracta width and odds of >/=1 grade reduction in

291 0.8 cm(2) vs. 0.4 cm(2); p < 0.01), and mean vena contracta width of 28% (1.2 cm vs.

292 TR severity was determined by the averaged vena contracta width on apical and parasternal inflow vi

293 The median vena contracta width was 8.5 mm in the group with small

294 ased effective regurgitant orifice area, and vena contracta with agreement in 68% of patients.

295 ial infarction, with mild to moderate MR (MR vena contracta, 4.6+/-0.1 mm; MR regurgitation fraction,

296 , P=0.02) and moderate mitral regurgitation (vena contracta, 5.0+/-1.0 versus 0.8+/-1.0 mm, P<0.0002)

297 versus mild to moderate with ring alone (MR vena contracta, 5.9+/-1.1 mm in controls, 0.5+/-0.08 wit

298 -derived effective regurgitant orifice area, vena contracta, color Doppler jet/left atrial area, left

299 n score index, MR regurgitation fraction and vena contracta, mitral annulus area, and posterior leafl

300 d significantly from moderate to trace-mild (vena contracta: 5+/-0.4 mm versus 2+/-0.7 mm, post-MR ve